Add the extracellular matrix in your 3D cellular assays

BIOMIMESYS® 3D technology is a natural HA-based scaffold to better mimic the tissue microenvironment and provide more predictive tools for drug development. The BIOMIMESYS® products are formed by crosslinking reaction of hydrosoluble modified hyaluronic acid and others matrix components with ADH (adipic acid dihydrazide), to mimic the extracellular matrix (ECM). Depending on the organ, ECM components vary and are present in different proportions, allowing a more or less dense and compact cellular environment. BIOMIMESYS® 3D technology allows us to reproduce the cell microenvironment of each organ.

Click here to get more information!

BIOMIMESYS® Brain
BIOMIMESYS® Brain
BIOMIMESYS® Liver
BIOMIMESYS® Liver
BIOMIMESYS® Oncology
BIOMIMESYS® Oncology
BIOMIMESYS® Adipose tissue
BIOMIMESYS® Adipose tissue
BIOMIMESYS® Custom
  • Hello tomorrow deep tech

R&D programs and partnerships

We are involved in amazing projects to improve medical and biological science, thanks to partners all around the world. Click on a project to get more information.
CHOlesterol Personalized INnovation (CHOPIN)

RHU CHOPIN

To ensure personalised treatment for familial hypercholesterolemia

ONCO3D

ONCO3D

To develop relevant 3D models of different tumors, in order to better assess the efficiency of anticancer therapies.

Nanosteam

Nanosteam

A holistic approach to address brain delivery

NEUROCELL3D

NEUROCELL3D

Face to the high failure of drug candidate in clinical trial, in particular involving the brain, we goal to develop more relevant and more predictive in vitro models for preclinical assessment, in the aim to early select molecules of interest, in term of efficacy and safety.

BioPharMEMS

BioPharMEMS

To design and industrialize new pharmacological in vitro assays for the screening of compounds/biopharmaceuticals in 3D

ScaLABle-MEAT

ScaLABle-MEAT

To develop the technological platform to produce lab-grown meats. The project is funded by EUREKA and the national funding agencies associated with the Eurostars program.

MIMLIVEROnChip

MIMLIVEROnChip

To develop a universal “plug-and-play” liver-on-chip platform mimicking the major events occurring in the liver sinusoid in order to predict the hepatoxicity of drugs.

VisuAI

VisuAI

To explore the use of AI technologies to improve different steps of 3D biological picture exploitation

News

Last news from HCS Pharma and biotechnologies!

Pourquoi BIOMIMESYS® va révolutionner la culture cellulaire

BIOMIMESYS® permet de cultiver des cellules en 3D dans des conditions identiques à celle d’un organe humain et en utilisant exclusivement des composés physiologiques. Nous sommes non seulement capables de proposer un environnement dont la composition est celle du tissu désiré, mais qui en plus a les mêmes propriétés mécaniques de rigidité et de porosité.

HCS Pharma is growing!

In October the expansion works started in HCS Pharma. The objective is to double the lab and office surface in the same building as our current premises, in the aim to expand BIOMIMESYS® production line Read more…

HCS Pharma @ CellME in Berlin

Our project leader Méryl and our CBO Mathieu are currently attending CellME (Cell Manufacturing & Engineering) Forum taking place these days in Berlin, Germany. Méryl had the chance to present his work and the advantages Read more…

Get in Touch

How can we help you?

Find us at the office

HCS Pharma – Siège de Lille
Biocentre Fleming Bat A
250 rue Salvador Allende
59120 LOOS
See on map

Give us a ring

+33 769 999 137
Only for customers please, if you have another interest use the form contact.

Contact Us